SEARCH RESULTS for assignee:"regenxbio"

Showing 1 to 2 of 2 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 16093363: Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF Fab

(A1) 20190127455: Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF Fab

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16093363: Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF Fab

(A1) 20190127455: Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF Fab

Assignee(s)